Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients

Medical and Pediatric Oncology

Volumn 28, Issue 1, 1997, Pages 22-26

  Kakadekar, A P ^a   Sandor, G G S ^a   Fryer, C ^a   Ka Wah Chan, ^a   Rogers, P C ^a   Pritchard, S ^a   Popov, R ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Anthracyclines; cardiomyopathy; Ewing's sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN;

ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL OBSERVATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ECHOCARDIOGRAPHY; EWING SARCOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SICK SINUS SYNDROME; SOFT TISSUE SARCOMA;

ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; RETROSPECTIVE STUDIES; SARCOMA; SARCOMA, EWING'S; SOFT TISSUE NEOPLASMS;

EID: 0031012091     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199701)28:1<22::AID-MPO5>3.0.CO;2-V     Document Type: Article

References (31)